Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Patent Reform Bill Hits Roadblock As Appropriations Cmte. Objects To PTO Fee Provision

This article was originally published in The Pink Sheet Daily

Executive Summary

Stakeholders are furiously lobbying representatives to get them to retain a provision that would end PTO fee diversion to other government programs.

You may also be interested in...



Patent Reform: Senate May Amend Two Provisions In House Bill

The Senate will vote on whether to limit debate on the House-passed patent reform bill when it reconvenes on Sept. 6. Senate Majority Leader Harry Reid, D-Nev., made a motion for the cloture vote before the August recess in hopes of getting a final bill through Congress quickly.

Patent Reform: Senate May Amend Two Provisions In House Bill

The Senate will vote on whether to limit debate on the House-passed patent reform bill when it reconvenes on Sept. 6. Senate Majority Leader Harry Reid, D-Nev., made a motion for the cloture vote before the August recess in hopes of getting a final bill through Congress quickly.

Patent Reform Bill Stumbles As Compromise On PTO Fee Diversion Divides House

The House rejects the manager's amendment to the bill, which included a last-minute agreement to keep PTO funding under the purview of the Appropriations Committee.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS072352

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel